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ABSTRACT
Lactobacillus reuteri is known as probiotics that effective to improve oral health. Objective: To analyze the effect
of L. reuteri Indonesian strain, towards Enterococcus faecalis and Candida albicans biofilm growth. Methods: This
study was conducted using biofilm assay. Each E. faecalis ATCC-29212 and C. albicans ATCC-10231 were cultured
in Brain Heart Infusion Broth, distributed into 96 well-microplate and incubated for 24h, 37°C, anaerobic condition
for E. faecalis and aerobic condition for C. albicans. L. reuteri LC382415 (Indonesian strain) was cultured in deMann Rogosa Sharpe Broth and diluted into different concentrations (108,106, and 104CFU/mL) subsequently, each
concentration distributed into biofilm well. Biofilm wells without probiotic was used as negative control. Biofilm
mass were measured using crystal-violet dye at 490nm using microplate-spectrophotometer. Data was statistically
analyzed by one-way ANOVA test, statistical significance set as p<0.05. Results: Significant reduction of biofilm
growth of E. faecalis and C. albicans after treatment with L. reuteri. The ideal concentration was found at L.
reuteri 108 CFU/mL with 79.2% E. faecalis biofilm reduction and L. reuteri 104 CFU/mL with 62.5% C. albicans
biofilm reduction compared to control (p<0.05) set at 100%. The ANOVA test results showed that L. reuteri in all
concentrations and all time periods in this study had the ability to inhibit biofilm growth of both species (p<0.05)
compared to negative control. Conclusion: L. reuteri Indonesian strain inhibit the biofilm growth of E. faecalis
and C. albicans. This antibiofilm effect may be useful in preventing biofilm growth in root canal.
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INTRODUCTION
One of the common problems in the oral cavity is
an infected root canal, with primary or secondary
infection.1 The infected root canal is a suitable medium
for the growth of pathogenic microorganisms. This
infection is caused by untreated dental caries, which
allow the pathogenic microorganisms to spread to
the apical region of the tooth and produce apical
inf lammation. 2 Without further treatment, this
periapical infection will become an acute or chronic
apical periodontitis, acute or chronic apical abscess,
or cyst, as well as cellulitis. Causes can include oral
cavity bacterial pathogens such as Enterococcus
faecalis, Staphylococcus aureus, Fusobacterium
nucleatum, Streptococcus spp., Eubacterium, and
Candida albicans.2,3

a virulence factor, survival mechanism, and resistance
that allow it to adapt to extreme environmental
conditions, such acidic, alkaline, hypotonic, or
hypertonic environments, over long periods. It is
capable of surviving at low nutrient conditions and at
temperatures ranging from 10 to 45°C.3,6
This bacterium has an important role in biofilm
development and biofilm formation contributes
to bacterial resistance against antibiotics and
phagocytosis.7 In a biofilm, the bacterial cells will
develop a tolerance to antibiotics at 10–1000 times
greater concentrations than are required to eliminate
planktonic cells. For these reasons, E. faecalis has
become a persistent organism. Although it makes up
only a small proportion of the flora in untreated canals,
it plays a major role in the etiology of persistent periradicular lesions after root canal treatment.7

Enterococcus faecalis is an oral microbe most
commonly found in infected root canals.4,5E. faecalis has
160
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In addition to bacteria, many Candida species, such
as C. albicans, C. dubliniensis, C. guilliermondii, C.
krusei, and C. tropicalis, are found in the oral cavity.
However, the most commonly found species is C.
albicans.8 This Candida is one of the normal flora found
in the oral cavity in 25–75% of the population, and it
also can be found in the human gastrointestinal tract.9,10
This species has the characteristics of an opportunistic
pathogen: it is harmless in healthy individuals, but
under certain conditions, it can cause infection in
the oral cavity.10,11 The infection can be caused by a
hormone imbalance, antibiotic overuse, long term use
of immunosuppressants, and the ability of C. albicans
to change into an invasive form.10 C. albicans has
collagenolytic activity as one of its virulence factors,
so it can use dentin as its nutrient source to increase its
colonization of the root canal. C. albicans has a role in
biofilm formation because of its ability to colonize the
dentinal surface and to penetrate deep into the dentinal
tubules.12 This biofilm formation makes Candida sp.
resistant to antifungal medications.13

coli ATCC 25922, L. monocytogenes ATCC 5313, S.
typhi NCDC 113, and E. faecalis NCDC 115.21 Each L.
reuteri strain has different ability on their effects as
antibacterial agent as well as anti-inflammatory agent.
Recent study showed the L. reuteri ATCC-55730
reduced the expression of the transcription level of
interleukin (IL)-8 and human-beta-defensin (hBD)-2 as
inflammatory factors.22 However, no studies have been
conducted to determine the effectiveness of L. reuteri
LC 382415 strain (Indonesian strain) against biofilms
of E. faecalis and C. albicans. Thus, the objective of
this study is to analyze the effect of L. reuteri LC
382415, towards E. faecalis and C. albicans biofilm
growth in vitro.

METHODS
Bacterial culture
E. faecalis ATCC 29212 and C. albicans ATCC 10231
were obtained from MiCORE Laboratory, Faculty
of Dentistry, Trisakti University and each of species
was cultured in BHI broth medium for 24 h at 37°C
under anaerobic conditions for E. faecalis and aerobic
conditions for C. albicans. L. reuteri LC 382415 was
cultured in Mann Rogosa Sharpe (MRS) broth medium
for 24 h at 37°C, under anaerobic conditions.

The most common treatment for root canal infections
such as apical periodontitis is endodontic treatment.
Irrigation and medications are often used to reduce
the load of pathogenic microorganisms in the root
canal. The most widely used irrigation materials are
sodium hypochlorite (NaOCl), chlorhexidine (2%),
and EDTA (17%). These materials all inhibit the
growth of E. faecalis and C. albicans, but each has its
inadequacies. NaOCl is highly toxic if it is exposed
to the periapical tissue, whereas chlorhexidine cannot
dissolve most tissues and EDTA has no antibacterial
activity.19 One of the most commonly used materials is
calcium hydroxide (Ca(OH)2), which has the potential
to decrease the numbers of pathogenic microorganism
in the root canal. However, E. faecalis and C. albicans
may sometimes show resistance to this material,
leading to the recurrence of infected root canals.5,14

Biofilm assay
E. faecalis ATCC 29212 and C. albicans ATCC 10231
were cultured, the optical density (OD) was measured
with a microplate reader (490 nm) and diluted until
reach bacterial concentration of Mc Farland 0.5 (1.5
× 108 CFU/µL). Each culture was homogenized with
a vortex mixer and distributed to a 96-well plate and
incubated for 48 h at 37°C under anaerobic conditions
for E. faecalis and aerobic conditions for C. albicans.
The culture supernatant was removed and the well-plate
was washed with phosphate buffered saline (PBS).
The L. reuteri LC 382415 culture was diluted (1 × 108,
1 × 106, and 1 × 104 CFU/mL), then distributed into
a 96-well microplate. Positive and negative controls
were also distributed into a 96-well microplate. NaOCl
(5.25%) was used as a positive control for E. faecalis
biofilm, and nystatine (100.000 IU) was used as a
positive control for C. albicans biofilm. BHI broth
was used as a negative control for E. faecalis and C.
albicans biofilms. The decreasing biofilm numbers
was observed after incubation in 37°C for 1, 3, 6, and
24 h under anaerobic conditions for E. faecalis and
aerobic conditions for C. albicans. The biofilms were
stained with crystal violet (0.5% w/v) by adding it to
a 96-well microplate and incubating for 15 minutes.
The dye solution was removed and 200 µL of absolute
ethanol was added to each well. The crystal violet dye
remaining in the wells was counted as biofilm numbers.
Biofilm inhibition was measured using crystal-violet
dye at 490 nm and a microplate-spectrophotometer.23
All treatment was done in triplicates and all bacterial
medium culture were use as blank control.

Probiotics are effective at enhancing oral health.15 One
of the common commercial probiotics that has shown
advantages in oral health is Lactobacillus reuteri,16 a
Gram-positive bacterium that can produce the glycerol
dehydratase enzyme to convert glycerol into reuterin
in the presence of glycerols.17,18 Reuterin is a broadspectrum antimicrobial agent that effectively inhibits
both Gram-positive and Gram-negative bacteria,
fungi, and protozoa by inhibiting DNA synthesis from
pathogenic microorganisms.10,19 L. reuteri has been
isolated from the saliva of Indonesian subjects and is
registered in the Genbank with accession number LC
382415.20
Previous studies indicated that L. reuteri DSM 17938
and L. reuteri PTA 5289 have antifungal activity
against five of six Candida species commonly found
in the oral cavity (i.e., C. albicans, C. dubliniensis,
C. glabrata, C. parapsilosis, and C. tropicalis.)10 L.
reuteri also shows antibacterial activity against E.
161
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Statistical analysis
The data were statistically analyzed by one-way
ANOVA test; statistical significance was set as p<0.05.
Statistical calculations were performed with SPSS
Statistics for Windows software version 20 (IBM,
USA).

RESULTS
Study showed that there was a significant reduction
of biofilm growth of E. faecalis after treatment with
L. reuteri. The most effective concentration of L.
reuteri was 1 × 108 CFU/mL (with OD value of 0.299)
for a 79.2% reduction in E. faecalis biofilm after 1
hour when compared to the control (with OD value
of 1.653) (p<0.05) set at 100% (Figure 1). Result also
showed that L. reuteri was effective on reducing the C.
albicans biofilms growth significantly (p<0.05). The
most effective concentration for L. reuteri was 1 × 104
CFU/mL (with OD value of 0.880) for a C. albicans
biofilm reduction of 62.5% in 1 hour when compared
to the control (with OD value of 3.302) (p<0.05) set at
100% (Figure 2).

Figure 1. E. faecalis biofilm reduction after treatment with
Lactobacillus reuteri in different concentration in 1h, 3h,
6h, and 24 hours incubation period (optical density). Biofilm
without L. reuteri treatment was used as negative control and
NaOCl as positive control.

DISCUSSION
E. faecalis and C. albicans are common microorganisms
found in infected root canals, and they have the etiology
of endodontic failure, also known as secondary root
canal infection. Therefore, an antimicrobial factor is
needed to inhibit the growth of these microorganisms.
L. reuteri is a probiotic that has antimicrobial and
antifungal properties and is useful for general human
health as well as oral cavity health. Some of the
advantages of L. reuteri probiotics are increased
immunity, treatment of diarrhea in children, inhibition
of Streptococcus mutans growth, which is one of the
dental caries etiology, and prevention of gingivitis.24,25

Figure 2. C. albicans biofilm reduction after treatment with
Lactobacillus reuteri in different concentration in 1h, 3h,
6h, and 24 hours incubation period (optical density). Biofilm
without L. reuteri treatment was used as negative control and
Nystatin as positive control.

Lactic acid and acetic acid produced by L. reuteri can
decrease the cellular pH in pathogenic microorganisms.
The inhibition of pathogenic bacterial growth is
caused by the ability acidic factors to penetrate the
cell membrane, dissociate into the alkali surrounding
the cell, and decreasing the pH in the cytoplasm.27
The production of bacteriocins and hydrogen peroxide
(H2O2) can damage the cell membrane of the pathogenic
bacteria and inhibit DNA synthesis. Therefore,
probiotics can prevent adhesion and further colonization
of pathogenic microorganisms on the tooth surface.28

Previous research indicated that L. reuteri has a
dehydratase enzyme that can transform glycerol into
reuterin.17,18 Reuterin is a broad-spectrum antimicrobial
factor that can inhibit Gram-positive and Gramnegative bacteria, fungi, and protozoa by inhibiting
microbial DNA synthesis.17 The mechanisms by which
probiotics inhibit microorganism biofilm formation
is by increasing the epithelial barrier function and
inducing mucus secretion, which simultaneously
increases bacterial adhesion on the surface and
inhibits pathogenic microorganism adhesion, through
competition with pathogenic microorganisms to
obtain nutrition, through interactions with receptors
on the surface of host cells, through production of
antimicrobial compounds, such as organic acids
(including lactic acid and acetic acid) and bacteriocin,
and by modulating the immune system of the host
cells.26

Aside from bacteriocins and organic acids produced by
most probiotic genera, some strains of L. reuteri also
produce a uniquely active antimicrobial compound,
reutericyclin, as their primary metabolite. Reutericyclin
differs from most bacteriocins produced by lactic acid
bacteria, because reutericyclin is actually a tetramic
acid derivative that possesses both bacteriostatic and
bactericidal activity against many Gram-positive and
162
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Gram-negative bacteria, including Staphylococcus
aureus, Enterococcus faecium, and Clostridium
difficile.29 A study conducted by Ganzle et al. (2000)
reported that reutericyclin showed dose-dependent
bactericidal activity, including cell lysis, against several
bacteria. This study also reported that E. faecalis was
the most sensitive indicator strain for reutericyclin,
with a minimum inhibitory concentration (MIC) of
0.05 mg/L.30 Although the precise mechanism of
reuterin remains unclear, but the antimicrobial property
was believed to be a result of damage to the microbial
cytoplasmic membrane.31
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The different incubation times in this study were
intended to reveal the most effective time required by
L. reuteri to decrease biofilm formation by E. faecalis
and C. albicans. The effects on biofilm formation
were related to the biofilm formation phases. In the
first few minutes, microorganisms in the oral cavity
attach to the dental surface or oral mucosa, and this
stage is considered reversible. If the microorganisms
are still attached to the surface, then the attachment
will become stronger and irreversible in the next 2–4
h. Within 6–12 h, these microorganisms will form an
extracellular polymeric substance (EPS) matrix that
will protect the microorganisms from any medications.
After 24 h, this biofilm will have matured. In this phase,
the microorganisms in the biofilm will be more resistant
to antimicrobial agents.32
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